DIBACT 1 1000,125;MG

The Brand Name DIBACT Has Generic Salt :: Ceftriaxone  DIBACT  Is From Company SVIZERE HC. Priced :: Rs. 125 DIBACT have Ceftriaxone is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR Generic Name...

DIBACT 1 250,31.25;MG

The Brand Name DIBACT Has Generic Salt :: Ceftriaxone  DIBACT  Is From Company SVIZERE HC. Priced :: Rs. 36 DIBACT have Ceftriaxone is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR Generic Name...

DIBACT 1 500,62.5;MG

The Brand Name DIBACT Has Generic Salt :: Ceftriaxone  DIBACT  Is From Company SVIZERE HC. Priced :: Rs. 69 DIBACT have Ceftriaxone is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR Generic Name...

BETEN 14 12.5MG

The Brand Name BETEN Has Generic Salt :: Atenolol  BETEN  Is From Company Svizera Priced :: Rs. N.I. BETEN have Atenolol is comes under Sub class Anti Hypertensives of  Main Class Cardiovascular System Main Medicine Class:: Cardiovascular System  Sub Medicine Class...

BETEN 14 25MG

The Brand Name BETEN Has Generic Salt :: Atenolol  BETEN  Is From Company SVIZERE HC. Priced :: Rs. 15 BETEN have Atenolol is Comes under class Anti Hypertensives of  Cardiovascular System Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti...

BETEN 10 5,25;MG

The Brand Name BETEN Has Generic Salt :: Amlodipine  BETEN  Is From Company Svizera Priced :: Rs. N.I. BETEN have Amlodipine is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR Generic Name Form...

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline